Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Pharma Foods International Co., Ltd. (2929)
Market Closed
2 Oct, 06:00 AM
JPX
All
(2)
JP
(1)
US
(1)
JPX
Primary
OTC PINK
¥
678.
00
-26
-3.6932%
¥
22.66B
Market Cap
-
P/E Ratio
0.16%
Div Yield
396,700
Volume
-
Eps
¥
704
Previous Close
Watching
Watch
Add Transaction
Day Range
667
702
Year Range
513
840
Want to track
2929
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Pharma Foods International Co., Ltd. (2929) Statistics
Valuation metrics
Market Cap
22.66B
Enterprise value
29.51B
Trailing P/E (ttm)
10.14
Forward P/E
4.1
PEG ratio
-0
Price/Sales (ttm)
0.32
Price/Book (mrq)
1.52
Enterprise Value/Revenue
0.47
Enterprise Value/EBITDA
8.76
Overview
Shares outstanding
29.04M
Float
19.51M
Shares short
-
% Held by insiders
0.33%
% Held by institutions
0.09%
Average volume (10 days)
260.47K
Average volume (90 days)
230.32K
Price summary
52-Week low
513
52-Week high
840
Beta
0.32
50-Day moving average
666
200-Day moving average
625.15
Dividends and splits
Forward annual dividend rate
25
Forward annual dividend yield
0.0387%
Trailing annual dividend rate
25
Trailing annual dividend yield
0.0361%
5-Year annual dividend yield
1.94%
Payout ratio
0.36
Dividend Date
31 Jul 2026
Ex-Dividend Date
31 Jul 2026
Last split factor
2:1
Last split Date
28 Jan 2015
Financials
Fiscal year
Fiscal year ends
31 Jul 2025
Most recent quarter (mrq)
31 Oct 2025
Profitability
Profit margin
0.03%
Operating margin
0.04%
Operational effectiveness
Return on assets
0.06%
Return on equity
0.19%
Income Statement
Revenue (ttm)
67.84B
Revenue per share (ttm)
2,182.29
Quarterly revenue growth (yoy)
0.1%
Gross profit (ttm)
54.59B
EBITDA
144M
Net income to common (ttm)
-1.68B
Diluted EPS (ttm)
68.62
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
7.69B
Total cash per share (mrq)
268.92
Total debt (mrq)
14.85B
Total Debt/Equity (mrq)
1.3
Current ratio (mrq)
1.26%
Book value per share (mrq)
454.56
Cash Flow
Cash flow statement
-3.89B
Levered free cash flow (LFCF)
-3.9B